Artículos por temáticas

Menopause triggers microglia-associated neuroinflammation in Parkinson's disease

Usman S, Mondal AC.

Brain Res. 2025 Jul 15;1859:149649. doi: 10.1016/j.brainres.2025.149649. Epub 2025 Apr 16.

Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background

Koros C, Stanitsa E, Angelopoulou E, Papageorgiou SG, Stefanis L.

Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624.

Recent advances in cell membrane-based biomimetic delivery systems for Parkinson's disease: Perspectives and challenges

Kaur J, Thakran A, Naqvi S.

Asian J Pharm Sci. 2025 Aug;20(4):101060. doi: 10.1016/j.ajps.2025.101060. Epub 2025 Apr 21.

The effect of exercise interventions on executive function in individuals with Parkinson's disease: A meta-analysis of main and moderator effects

Chang CL, Wu SY, Ling DI, Tsai CL.

Biol Psychol. 2025 Jul;199:109061. doi: 10.1016/j.biopsycho.2025.109061. Epub 2025 Jun 6.

From Hopelessness to Hope: Addressing Demoralization in Parkinson's Disease

McDaniels B, Bradley ER, Pontone G, Pushparatnam K, Mathur S, Miller R, Subramanian I.

Mov Disord Clin Pract. 2025 Jul 1. doi: 10.1002/mdc3.70209. Online ahead of print.

Spinal Cord Stimulation Failed to Improve Parkinson's Disease Symptoms in Randomized Crossover Double-Blinded Evaluation

Carra RB, Garcia LÁL, Menezes JR, Capato T, Santos F, Barbosa ER, Duarte KP, Godinho F, Teixeira MJ, de Andrade DC, Cury RG.

Mov Disord. 2025 Jul;40(7):1279-1290. doi: 10.1002/mds.30187. Epub 2025 Apr 2.

NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies

Zhang K, Wen M, Nan X, Zhao S, Li H, Ai Y, Zhu H.

Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.

Effect of group virtual exercise on people with Parkinson's disease: A randomized controlled trial

Fishel SC, Hotchkiss ME, McNamara CA, Sevilla KM, Brown SA.

Physiother Theory Pract. 2025 Jul;41(7):1355-1365. doi: 10.1080/09593985.2024.2420015. Epub 2024 Oct 27.

Alpha-synuclein in Parkinson's disease: Embracing debate, exercising skepticism

Espay AJ, Lees AJ, Cardoso F, Frucht SJ, Erskine D, Sturchio A, Imarisio A, Hoffmann C, Montemagno KT, Naudi-Fabra S, Milovanovic D, Halliday GM, Manfredsson FP.

Parkinsonism Relat Disord. 2025 Jul;136:107874. doi: 10.1016/j.parkreldis.2025.107874. Epub 2025 May 15.

Genetic and immunological regulation of gut Microbiota: The Roles of TLRs, CLRs, and key proteins in microbial homeostasis and disease

Ayoub M, Chmouni YA, Damaa N, Eter A, Medawar H, Ghadieh HE, Bazzi S, Khattar ZA, Azar S, Harb F.

Gene. 2025 Jul 5;955:149469. doi: 10.1016/j.gene.2025.149469. Epub 2025 Apr 4.

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential

Yan Y, Maisenbacher M, Huang C, Fan S.

Pharmacol Res. 2025 Aug;218:107849. doi: 10.1016/j.phrs.2025.107849. Epub 2025 Jul 2.

Continuous Dopaminergic Stimulation-Based Levodopa Treatment in Patients with Early to Mid-Stage Parkinson's Disease: A Systematic Review and Meta-Analysis

Tang R, Zhang S, Sun R, Xu J, Hu Y, Tan H, Chen L.

Neurol Ther. 2025 Aug;14(4):1197-1208. doi: 10.1007/s40120-025-00764-4. Epub 2025 May 28.

Predictors of discontinuation in foslevodopa/foscarbidopa therapy for Parkinson's disease

Nishikawa N, Hatano T, Kamiyama D, Kamo H, Oji Y, Abe C, Shinada J, Oyama G, Hattori N.

Parkinsonism Relat Disord. 2025 Jul;136:107896. doi: 10.1016/j.parkreldis.2025.107896. Epub 2025 May 26.

Machine learning for Parkinson's disease: a comprehensive review of datasets, algorithms, and challenges

Shokrpour S, MoghadamFarid A, Bazzaz Abkenar S, Haghi Kashani M, Akbari M, Sarvizadeh M.

NPJ Parkinsons Dis. 2025 Jul 1;11(1):187. doi: 10.1038/s41531-025-01025-9.

New Insights on the Potential Role of Pyroptosis in Parkinson's Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics

Saad HM, Atef E, Elsayed AE.

Mol Neurobiol. 2025 Jul;62(7):9365-9384. doi: 10.1007/s12035-025-04818-4. Epub 2025 Mar 18.